Official rates of banking metals from national bank as of December 03
Source: Central Bank
On December, 5 and 6 the «Kyivan Rus Park» invites to make an exiting journey to the epoch of Kievan Rus, and visit an alive medieval town.
Not far from Kiev guests will relax in an ecologically clean place and get a huge positive charge from the architecture of Ancient Kiev, horseback riding, extreme attractions, historical exhibitions… And all these in a real medieval town!
Ancient Kyiv is open 10:00 – 18:00.
The ticket price: a full adult ticket – 200 UAH, for pensioners and students – 150 UAH, for schoolchildren – 80 UAH, for preschool children – free.
Ancient Kyiv in the «Kyivan Rus Park» is located in Kyiv region, Obukhiv district, the vill. Kopachiv.
Details on the website www.parkkyivrus.com
The Interfax subscribers can save money with the “openbusiness-20” promo code for a 20%-discount for a full price adult ticket to the Principality of Kyivan Rus:
– by previous order by tel.: +38 044 461-99-37, +38 050 385-20-35
– or at the cash desk at the entrance to the «Kyivan Rus Park».
TOP 20 countries Ukraine has posted the highest surplus of trade in goods in Jan-Aug (thsd usd).
SSC of Ukraine
The Verkhovna Rada’s National Health Committee has recommended that parliament support a bill that makes it possible to shorten the approval period for clinical trials and registration of vaccines and drugs against coronavirus disease (COVID-19).
“The profile committee recommended the Verkhovna Rada to support bill No. 4314. It makes it possible to shorten the approval period for clinical trials and registration of vaccines and drugs against COVID-19,” the Servant of the People party said on Facebook on Wednesday, December 2.
According to the head of the Verkhovna Rada of Ukraine Committee on Public Health, Medical Assistance and Medical Insurance Mykhailo Radutsky, the adoption of bill No. 4314 will reduce the burden on the healthcare system.
“Vaccination of a large number of patients will reduce the burden on the health care system of Ukraine,” Radutsky said.
“And thanks to the bill, this will become possible. After all, the involvement of Ukraine in clinical trials of vaccines would allow to vaccinate part of the population already now. Likewise, reducing the time for state registration of vaccines will speed up their full-scale use,” the Servant of the People said.
The shareholders of Alfa-Garant Insurance Company (Kyiv) on November 20, 2020 decided to reduce the charter capital, which currently amounts to UAH 65 million, according to the insurer’s website.
As noted, the decrease will take place through a proportional reduction in the nominal value of the deposits of all members of Alfa-Garant without changing the size of the shares of each participant in percent and without refunds of money contributed to the charter capital.
The company informs that the decision to reduce the charter capital was made in accordance with the requirements of Ukrainian legislation, including the laws on limited and additional liability companies, on insurance, on financial services and state regulation of financial services markets and does not affect the company’s financial stability.
According to the reporting on the results of work of Alfa-Garant for the nine months of 2020, the excess of the actual solvency margin (UAH 79.075 million) over the standard (UAH 46.406 million) is UAH 32.669 million.
Alfa-Garant has been operating in the insurance market since 2003 in the segment of risk insurance of individuals and legal entities.
The Lithuanian company Snaige, the only manufacturer of household refrigerators and freezing equipment in the Baltic States, in January-September 2020 reduced its revenue in Ukraine by 16.3% compared to the same period in 2019, to EUR 4.504 million.
According to the published unaudited annual report of the company, Snaige’s loss in Ukraine during this period decreased by one third, amounting to EUR 2,000.
In general, the consolidated unaudited turnover of Snaige for January-September 2020 decreased by 14% compared to the nine months of last year, to EUR 22.3 million.
According to Snaige AB CEO Mindaugas Sologubas, quoted in the report, the decline in sales is a consequence of the global pandemic and quarantine.
“Due to the restrictions imposed by the quarantine, the company’s plant in Alytus was forced to work at partial capacity for several months in the spring, some employees were idle. There was a shortage of supplies, as many suppliers were located in the countries affected by the pandemic,” he said.
As noted, in the third quarter of this year, the company’s sales recovered and almost reached the level of the third quarter of last year, but this was not enough to cover the losses incurred in the spring.
At the same time, the company’s unaudited consolidated EBITDA more than doubled in three quarters, to EUR 1.7 million.
